pretickt

The Cooper Companies, Inc. (COO)

Healthcare · end-of-day data as of Oct 16, 2026

The Cooper Companies, Inc.
COO · $11.02B
$57.94-17.6%last 60 sessions · close Oct 16, 2026
$53.27$84.3252 weeks
Hold · 17 analystsPT $58.46 +0.9%
  • P/E vs own-49.1%
  • P/E vs sector-29.8%
  • Target upside+0.9%
  • Off 52w high-31.3%
  • Insiders$1.88M
  • FCF yield+6.2%
  • Earnings in48d
  • Trendbearish
  • Sector▲ +16.0%
  • RSI50
  • MA20×50↑ in ~18d
  • Volume0.9x
  • Support-7.2%
  • Resistance+2.2%

The average 12-month analyst price target for COO is $58.46, 0.9% above the last close of $57.94 on Oct 16, 2026; targets range from $50.35 to $73.58. Rating consensus: Hold.

Snapshot

  • P/E19.8x
  • P/E vs sector-29.8%
  • P/E vs own-49.1%
  • Target upside+0.9%
  • ConsensusHold
  • Market cap$11.02B
  • FCF yield+6.2%
  • Insiders$1.88M
  • Earnings in48d
  • News

Why it moved

The Cooper Companies, Inc. (COO) rose 0.9% on Oct 16, 2026.

The market (SPY) fell 1.1%; Healthcare stocks fell 0.8%. Most of the move is specific to COO.

Market (SPY)-1.1%
Healthcare sector+0.4%
COO specific+1.7%

1 story on the day (30-day average 1.9).

Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.

Price and events

⇔⇕$55.29$64.29$73.30$82.30Oct 25Jan 26Apr 26Jul 26Oct 26AEEEEAE

Last close $57.94 · -19.0% over 1y · E earnings · D dividend · S split · A analyst rating change

Technicals

  • Trendbearish
  • Sector▲ +16.0%
  • MAs20▲ 50▼ 100▼ 200▼
  • Above MAs1 of 4 above
  • MA20×50↑ in ~18d
  • RSI50
  • Support-7.2%
  • Resistance+2.2%
  • Off 52w high-31.3%
  • Off ATH-49.1%
  • 52w range$57.94
  • Bollingerupper half
  • MACD0.74
  • ATR+2.9%
  • Volume0.9x

Analyst price targets

Low$50.35
Average$58.46
Median$59.73
High$73.58
Upside+0.9%

9 firms with a target in the last 12 months · last close $57.94 · as of Oct 16, 2026

⇔⇕$47.58$62.80$78.01$93.22$108Oct 25Mar 26Aug 26Jan 27Jun 27+73%+22%+68%+13%+53%+5%-12%
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets

Strong buy 2 · Buy 3 · Hold 12 · Sell 0 · Strong sell 0

Revenue and free cash flow

Q3 FY2026: Revenue +0.6% year over year, free cash flow 25.6% of revenue, operating margin 20.9%.

RevenueFree cash flow
Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Q3 FY2026Jul 31, 2026$1.07B2.24$273M62.4%20.9%40.6%
Q2 FY2026Apr 30, 2026$1.08B-0.40$96.4M68.0%-2.9%-7.2%
Q1 FY2026Jan 31, 2026$1.02B0.66$159M67.9%20.8%12.8%
Q4 FY2025Oct 31, 2025$1.07B0.43$150M56.4%13.2%7.9%
Q3 FY2025Jul 31, 2025$1.06B0.49$165M65.3%16.6%9.3%
Q2 FY2025Apr 30, 2025$1B0.44$18.1M67.8%18.4%8.7%
Q1 FY2025Jan 31, 2025$965M0.52$101M68.4%18.9%10.8%
Q4 FY2024Oct 31, 2024$1.02B0.58$128M66.5%19.5%11.5%

Peers

20D
1ISRGIntuitive Surgical, Inc.$426.70-0.3%-28.0%+12.1%48.5$151B
2BDXBecton, Dickinson and Company$191.75-1.0%-1.0%-6.2%57.8$52.23B
3RMDResMed Inc.$238.97-1.3%-12.7%+3.7%23.0$33.61B
4WSTWest Pharmaceutical Services, Inc.$384.02+0.3%0.0%+1.9%49.1$27.03B
5SOLVSolventum Corporation$85.81-2.3%-7.2%+3.6%10.5$14.61B
6BAXBaxter International Inc.$25.28-1.9%-10.8%-14.8%—$13.07B
7COOThe Cooper Companies, Inc.$57.94+0.9%-31.3%+0.9%19.8$11.02B
8UHSUniversal Health Services, Inc.$185.10-1.2%-23.9%+11.1%7.6$10.91B

Data as of Oct 16, 2026 close.

Latest news